Reinvigorated T-cell numbers counterbalance tumour burden – Nature.com
|
Reinvigorated T-cell numbers counterbalance tumour burden
Nature.com Blockade of the programmed cell death protein 1 (PD-1) immune checkpoint has defined a new era of anticancer therapy. However, only a minority of patients respond to PD-1 blockade, and reliable predictive biomarkers have proved elusive. In a recently … |
